AVITA Medical, Inc.'s (RCEL) CEO Mike Perry on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/27/21
U.S. Food and Drug Administration Approves Expanded Use of the RECELL® System for the Treatment of Extensive Burns and Pediatric PatientsGlobeNewsWire • 06/10/21
AVITA Medical, Inc. Appoints Two New Non-Executive Members to the Board of DirectorsGlobeNewsWire • 06/01/21
AVITA Medical's (RCEL) CEO Mike Perry on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/14/21
All You Need to Know About AVITA Medical, Inc. (RCEL) Rating Upgrade to BuyZacks Investment Research • 04/14/21
15 RECELL® System Abstracts Accepted for Presentation at 53ʳᵈ Annual American Burn Association MeetingGlobeNewsWire • 03/30/21
Avita Medical, Inc. Announces Closing of Offering of 3,214,250 Shares of Common StockGlobeNewsWire • 03/01/21
AVITA Therapeutics, Inc. (RCEL) CEO Mike Perry on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/12/21
AVITA Medical to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools ConferenceGlobeNewsWire • 02/03/21